NCT03803566

Brief Summary

The objective of the clinical trial is to evaluate the mediating influence of force control on the pegboard times of adults (50-89 years) who are stratified into groups of faster and slower pegboard times. The hypothesis is that practice of either a pegboard test or a force-control task will reduce pegboard times, but the decrease will be greater and less similar after the two practice interventions for the slower group of participants. The outcomes are expected to demonstrate that force control is a modifiable mediator of pegboard times for this cohort, but the effect will be stronger for the group with faster pegboard times.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
1mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Aug 2025Jul 2026

First Submitted

Initial submission to the registry

January 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 14, 2019

Completed
6.6 years until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

November 16, 2021

Status Verified

November 1, 2021

Enrollment Period

3 months

First QC Date

January 10, 2019

Last Update Submit

November 12, 2021

Conditions

Keywords

Manual dexterity

Outcome Measures

Primary Outcomes (4)

  • Grooved pegboard test

    Time to complete the test as quickly as possible

    Changes from baseline (week 1) at weeks 4 and 7

  • 9-hole pegboard test

    Time to complete the test as quickly as possible

    Changes from baseline (week 1) at weeks 4 and 7

  • Jebsen Hand Function test

    Time to complete the test as quickly as possible

    Changes from baseline (week 1) at weeks 4 and 7

  • Force control

    The coefficient of variation for force when subjects exert a constant submaximal force

    Changes from baseline (week 1) at weeks 4 and 7

Secondary Outcomes (5)

  • EMG amplitude

    Changes from baseline (week 1) at weeks 4 and 7

  • MVC force

    Changes from baseline (week 1) at weeks 4 and 7

  • 1-RM load

    Changes from baseline (week 1) at weeks 4 and 7

  • Index finger acceleration

    Changes from baseline (week 1) at weeks 4 and 7

  • Motor unit discharge rates

    Changes from baseline (week 1) at weeks 4 and 7

Study Arms (2)

Faster

EXPERIMENTAL

This group will comprise participants who complete the grooved pegboard test at baseline with a time of less than 71 seconds. One half of the members in this group will perform the two interventions in the order of pegboard practice and then force control practice, whereas the other half of the group will perform the two practice interventions in the opposite order.

Other: Pegboard practiceOther: Force control practice

Slower

EXPERIMENTAL

This group will comprise participants who complete the grooved pegboard test at baseline with a time of greater than 70 seconds. One half of the members in this group will perform the two interventions in the order of pegboard practice and then force control practice, whereas the other half of the group will perform the two practice interventions in the opposite order.

Other: Pegboard practiceOther: Force control practice

Interventions

Practice of the grooved pegboard test

FasterSlower

Practice performing steady muscle contractions

FasterSlower

Eligibility Criteria

Age50 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to read, write, and speak English
  • Able to arrange transportation to the Boulder campus

You may not qualify if:

  • Cognitive impairment
  • Major psychiatric condition
  • Unstable depressive disorder
  • Progressive neurological, muscular, cardiovascular, or skeletal disorder
  • Chronic pain condition
  • Currently taking medication known to influence neuromuscular function
  • Recent hospitalization
  • Unable to attend 12 practice sessions in 6 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Boulder

Boulder, Colorado, 80309, United States

Location

Study Officials

  • Roger Enoka, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 10, 2019

First Posted

January 14, 2019

Study Start

August 1, 2025

Primary Completion

November 1, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

November 16, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations